Skip to main content
Heart Donate
Heart Donate
Search

Support WBUR

Drug Combination Slows Progression Of ALS And Could Mark 'New Era' In Treatment

03:34
Patients with a fast-progressing form of ALS who got daily doses of an experimental two-drug combination called AMX0035 scored higher on a standard measure of function than patients who didn't get the drug. (Zephyr/Science Source)
Patients with a fast-progressing form of ALS who got daily doses of an experimental two-drug combination called AMX0035 scored higher on a standard measure of function than patients who didn't get the drug. (Zephyr/Science Source)

Related:

Support WBUR

Support WBUR

Listen Live
Loading...